日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters

高级别浆液性输卵管卵巢癌中的三级淋巴结构:解剖部位的重要性

Westbom-Fremer, Sofia; Tran, Lena; Ebbesson, Anna; Martin de la Fuente, Laura; Jönsson, Jenny-Maria; Kannisto, Päivi; Veerla, Srinivas; Hedenfalk, Ingrid

Molecular patterns of resistance to immune checkpoint blockade in melanoma

黑色素瘤免疫检查点阻断耐药的分子模式

Lauss, Martin; Phung, Bengt; Borch, Troels Holz; Harbst, Katja; Kaminska, Kamila; Ebbesson, Anna; Hedenfalk, Ingrid; Yuan, Joan; Nielsen, Kari; Ingvar, Christian; Carneiro, Ana; Isaksson, Karolin; Pietras, Kristian; Svane, Inge Marie; Donia, Marco; Jönsson, Göran

Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer

纵向分子分析阐明乳腺癌的免疫代谢动态

Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer

整合组学方法揭示了表观遗传事件如何解释和预测乳腺癌患者对新辅助化疗和贝伐单抗的反应。

Fleischer, Thomas; Haugen, Mads Haugland; Ankill, Jørgen; Silwal-Pandit, Laxmi; Børresen-Dale, Anne-Lise; Hedenfalk, Ingrid; Hatschek, Thomas; Tost, Jörg; Engebraaten, Olav; Kristensen, Vessela N

Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma

卵巢子宫内膜异位症及随后诊断的卵巢癌的基因组改变

Linder, A; Westbom-Fremer, S; Mateoiu, C; Olsson Widjaja, A; Österlund, T; Veerla, S; Ståhlberg, A; Ulfenborg, B; Hedenfalk, I; Sundfeldt, K

Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells

乳腺癌相关 CD169+ 巨噬细胞具有广泛的免疫抑制功能,但可增强活化 B 细胞的抗体分泌

Frida Björk Gunnarsdottir, Oscar Briem, Aida Yifter Lindgren, Eva Källberg, Cajsa Andersen, Robert Grenthe, Cassandra Rosenqvist, Camilla Rydberg Millrud, Mika Wallgren, Hannah Viklund, Daniel Bexell, Martin E Johansson, Ingrid Hedenfalk, Catharina Hagerling, Karin Leandersson

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer

预测顺铂敏感性的深度表格数据学习模型可识别癌症中的 BCL2L1 依赖性

Ahmad Nasimian, Mehreen Ahmed, Ingrid Hedenfalk, Julhash U Kazi

CD169+ Macrophages in Primary Breast Tumors Associate with Tertiary Lymphoid Structures, Tregs and a Worse Prognosis for Patients with Advanced Breast Cancer

乳腺原发性肿瘤中的 CD169+ 巨噬细胞与三级淋巴结构、Treg 以及晚期乳腺癌患者的预后较差相关

Oscar Briem, Eva Källberg, Siker Kimbung, Srinivas Veerla, Jenny Stenström, Thomas Hatschek, Catharina Hagerling, Ingrid Hedenfalk, Karin Leandersson

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

基于RNA测序的单样本分子亚型和复发风险预测因子在早期乳腺癌临床评估中的应用

Staaf, Johan; Häkkinen, Jari; Hegardt, Cecilia; Saal, Lao H; Kimbung, Siker; Hedenfalk, Ingrid; Lien, Tonje; Sørlie, Therese; Naume, Bjørn; Russnes, Hege; Marcone, Rachel; Ayyanan, Ayyakkannu; Brisken, Cathrin; Malterling, Rebecka R; Asking, Bengt; Olofsson, Helena; Lindman, Henrik; Bendahl, Pär-Ola; Ehinger, Anna; Larsson, Christer; Loman, Niklas; Rydén, Lisa; Malmberg, Martin; Borg, Åke; Vallon-Christersson, Johan

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer

基于基因表达和免疫组织化学的生物标志物在穿刺活检中的评估可靠性如何?一项针对早期乳腺癌配对穿刺活检和手术标本的研究

Saghir, Hani; Veerla, Srinivas; Malmberg, Martin; Rydén, Lisa; Ehinger, Anna; Saal, Lao H; Vallon-Christersson, Johan; Borg, Åke; Hegardt, Cecilia; Larsson, Christer; Haidar, Alaa; Hedenfalk, Ingrid; Loman, Niklas; Kimbung, Siker